News & events Upcoming events XXIX International Congress of Neurology and Neurosurgery Oct 14, 2021 - Oct 17, 2021 Punta Cana , Dominican Republic More info and meet us there Webinar: CSF-based biomarkers to support the diagnosis of Alzheimer’s disease Oct 27, 2021 - Oct 27, 2021 Webinar , Belgium More info and meet us there LABCLIN 2021 - Congreso Nacional del Laboratorio Clínico Nov 7, 2021 - Nov 13, 2021 Virtual event , Spain More info and meet us there See all upcoming events Latest news Fujirebio Europe announces CE marking of the fully automated Lumipulse® G SARS-CoV-2 antigen assay and the rapid antigen device ESPLINE® SARS-CoV-2 Aug 11, 2020 With these new products Fujirebio further positions itself as a leading global provider of immunoassay testing solutions to the IVD industry... Read more Fujirebio Europe launches the Lumipulse® G Aldosterone and Renin assays for fully automated quantitative determination of aldosterone and active renin Jul 1, 2020 Fujirebio Europe announces the release of the Lumipulse G Aldosterone and Renin assays for the fully automated quantitative determination of... Read more iAMP COVID-19 Detection kit, a molecular SARS-CoV-2 detection assay distributed by Fujirebio Europe, is now CE marked May 12, 2020 Fujirebio Europe today announced that the molecular IVD assay iAMP COVID-19 Detection Kit from its partner Atila Biosystems, Inc. has been... Read more Fujirebio Europe launches the automated Lumipulse® G SCC assay for the quantitative measurement of squamous cell carcinoma antigen Apr 24, 2020 Fujirebio Europe announces the release of the Lumipulse G SCC assay for the automated quantitative measurement of squamous cell carcinoma... Read more Statement on the impact of coronavirus disease COVID-19 on our operations Apr 14, 2020 The novel coronavirus disease Covid-19 first reported in Wuhan, China in late 2019 has spread far beyond China, and now affects... Read more Fujirebio Europe launches iAMP COVID-19, a new molecular detection assay that eliminates the need for RNA extraction Apr 8, 2020 Fujirebio Europe N.V. today announced the commercial launch of the iAMP COVID-19 molecular assay from its partner Atila Biosystems, Inc... Read more Load More
XXIX International Congress of Neurology and Neurosurgery Oct 14, 2021 - Oct 17, 2021 Punta Cana , Dominican Republic More info and meet us there
Webinar: CSF-based biomarkers to support the diagnosis of Alzheimer’s disease Oct 27, 2021 - Oct 27, 2021 Webinar , Belgium More info and meet us there
LABCLIN 2021 - Congreso Nacional del Laboratorio Clínico Nov 7, 2021 - Nov 13, 2021 Virtual event , Spain More info and meet us there
Fujirebio Europe announces CE marking of the fully automated Lumipulse® G SARS-CoV-2 antigen assay and the rapid antigen device ESPLINE® SARS-CoV-2 Aug 11, 2020 With these new products Fujirebio further positions itself as a leading global provider of immunoassay testing solutions to the IVD industry... Read more
Fujirebio Europe launches the Lumipulse® G Aldosterone and Renin assays for fully automated quantitative determination of aldosterone and active renin Jul 1, 2020 Fujirebio Europe announces the release of the Lumipulse G Aldosterone and Renin assays for the fully automated quantitative determination of... Read more
iAMP COVID-19 Detection kit, a molecular SARS-CoV-2 detection assay distributed by Fujirebio Europe, is now CE marked May 12, 2020 Fujirebio Europe today announced that the molecular IVD assay iAMP COVID-19 Detection Kit from its partner Atila Biosystems, Inc. has been... Read more
Fujirebio Europe launches the automated Lumipulse® G SCC assay for the quantitative measurement of squamous cell carcinoma antigen Apr 24, 2020 Fujirebio Europe announces the release of the Lumipulse G SCC assay for the automated quantitative measurement of squamous cell carcinoma... Read more
Statement on the impact of coronavirus disease COVID-19 on our operations Apr 14, 2020 The novel coronavirus disease Covid-19 first reported in Wuhan, China in late 2019 has spread far beyond China, and now affects... Read more
Fujirebio Europe launches iAMP COVID-19, a new molecular detection assay that eliminates the need for RNA extraction Apr 8, 2020 Fujirebio Europe N.V. today announced the commercial launch of the iAMP COVID-19 molecular assay from its partner Atila Biosystems, Inc... Read more
